Long-term estradiol replacement decreases contractility of guinea pig coronary arteries to the thromboxane mimetic U46619

Circulation

Volumn 95, Issue 3, 1997, Pages 709-714

  Thompson, Loren P ^a,b   Weiner, Carl P ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

contractility; endothelium; estradiol; thromboxane; vasoconstriction

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ESTRADIOL; GUANYLATE CYCLASE INHIBITOR; METHYLENE BLUE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; THROMBOXANE RECEPTOR STIMULATING AGENT;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG MECHANISM; ESTROGEN THERAPY; GUINEA PIG; HEART PROTECTION; HORMONE SUBSTITUTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULAR ENDOTHELIUM;

EID: 0031041419     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.3.709     Document Type: Article

References (13)

1. McGill HC, Stern MP. Sex and atherosclerosis. Atheroscler Rev. 1979;4:157-242.
2. Kalin MF, Zumoff B. Sex hormones and coronary disease: a review of the clinical studies. Steroids. 1990;55:330-352.
3. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham Study. Ann Intern Med. 1983;85:447-452.
4. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiological evidence. Prev Med. 1991;20:47-63.
5. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. Ann Intern Med. 1978;89:157-161.
6. Barrett-Connor E, Bush TL. Estrogen replacement and coronary heart disease. Cardiovasc Clin. 1989;19:159-172.
7. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016-1037.
8. Nabulski M, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 1993;328:1069-1075.
9. Williams JK, Adams MR, Herington DM, Clarkson TB. Short-term administration of estrogen and vascular response of atherosclerotic coronary arteries. J Am Coll Cardiol. 1992;20:452-457.
10. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990;81:1680-1687.
11. Von Eiff AW, Lutz HM, Gries J, Kretzchmar R. The protective mechanism of estrogen on high blood pressure. Basic Res Cardiol. 1985;80:191-201.
12. The Coronary Drug Project. Findings leading to discontinuation of the 2.5 mg per day estrogen group. JAMA. 1973;226:652-657.
13. Ory HW. The health effect of fertility control. In: Contraception: Science, Technology, and Application. Washington, DC: National Academy of Sciences; 1979:110-131.